Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for March 3, 2025 at 4:30 P.M. Eastern Time
GERMANTOWN, Md., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its fourth quarter and full year 2024 financial results after market close on Monday, March 3, 2025.
Management will hold a conference call to review the Company's fourth quarter and full year 2024 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by navigating to 'Investor Relations,' and then 'Events & Publications,' and will be archived there for future reference. To listen to the conference call, please dial 1-800-445-7795 (US/Canada) or 1-785-424-1699 (International), passcode SENSQ4, approximately ten to five minutes prior to start time.
About SenseonicsSenseonics Holdings, Inc. ("Senseonics") is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems Eversense® 365 and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.
Senseonics Investor Contact
Jeremy FefferLifeSci Advisorsinvestors@senseonics.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
High Growth Tech Stocks To Watch In Europe June 2025
As the European markets experience a boost, with the STOXX Europe 600 Index climbing by 0.90% amid easing inflation and supportive monetary policy from the European Central Bank, investors are increasingly focusing on high-growth sectors such as technology. In this environment, identifying promising tech stocks involves looking for companies that can leverage favorable economic conditions and technological advancements to drive substantial growth. Name Revenue Growth Earnings Growth Growth Rating Intellego Technologies 30.80% 45.66% ★★★★★★ Archos 21.07% 36.58% ★★★★★★ KebNi 21.51% 66.96% ★★★★★★ Pharma Mar 29.61% 44.92% ★★★★★★ Bonesupport Holding 29.14% 56.14% ★★★★★★ argenx 21.50% 26.61% ★★★★★★ Skolon 31.51% 99.52% ★★★★★★ Xbrane Biopharma 24.95% 56.77% ★★★★★★ Diamyd Medical 86.29% 93.04% ★★★★★★ Elliptic Laboratories 36.33% 78.99% ★★★★★★ Click here to see the full list of 226 stocks from our European High Growth Tech and AI Stocks screener. Let's explore several standout options from the results in the screener. Simply Wall St Growth Rating: ★★★★★★ Overview: argenx SE is a commercial-stage biopharma company focused on developing therapies for autoimmune diseases across several countries including the United States, Japan, China, and the Netherlands, with a market cap of €31.52 billion. Operations: argenx focuses on developing therapies for autoimmune diseases, generating revenue primarily from its biotechnology segment, which reported $2.64 billion. The company's operations span multiple countries, including the United States, Japan, China, and the Netherlands. argenx SE has demonstrated remarkable growth with a surge in revenue to $807.37 million, doubling from the previous year's $412.51 million, alongside transitioning from a net loss to a substantial net income of $169.47 million. This financial turnaround is underscored by robust R&D commitments, crucial for sustaining innovation and competitiveness in the biotech landscape. The firm's recent CHMP nod for VYVGART® in CIDP treatment further highlights its strategic focus on expanding therapeutic applications, promising continued relevance and impact within the healthcare sector. Click here to discover the nuances of argenx with our detailed analytical health report. Understand argenx's track record by examining our Past report. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Believe S.A. is a company that offers digital music services to independent labels and local artists across various regions including France, Germany, the rest of Europe, the Americas, Asia, Oceania, and the Pacific with a market cap of approximately €1.72 billion. Operations: The company's revenue primarily comes from Premium Solutions, generating €924.24 million, while Automated Solutions contribute €64.59 million. Believe, a European tech entity, is navigating its path towards profitability with expected earnings growth of 96.9% annually. Despite current unprofitability, its revenue growth outpaces the French market's average at 13.4% per year compared to 5%. This growth trajectory is supported by strategic moves such as the proposed acquisition by TCMI Inc., EQT X, and Denis Ladegaillerie for a €57.9 million stake, enhancing financial stability and market presence. Moreover, Believe's commitment to R&D aligns with industry demands for continuous innovation, ensuring it remains competitive in the dynamic tech landscape. Get an in-depth perspective on Believe's performance by reading our health report here. Examine Believe's past performance report to understand how it has performed in the past. Simply Wall St Growth Rating: ★★★★★☆ Overview: Comet Holding AG, along with its subsidiaries, delivers X-ray and radio frequency (RF) power technology solutions globally across Europe, North America, and Asia, with a market capitalization of CHF1.79 billion. Operations: The company generates revenue through three main segments: X-Ray Systems (CHF115.89 million), Industrial X-Ray Modules (CHF94.57 million), and Plasma Control Technologies (CHF247.39 million). Comet Holding AG, a Swiss tech firm, is making notable strides with an earnings growth of 37.3% annually, significantly outpacing the local market's average of 10.7%. This robust performance is further underscored by its revenue increase of 12.2% per year, which also surpasses the Swiss market growth rate of 4.2%. Notably, Comet's commitment to innovation is evident in its R&D spending, crucial for maintaining technological leadership in a competitive sector. Recent corporate actions include electing Benjamin Loh as Chairman and approving a dividend increase to CHF 1.50 per share, signaling strong governance and shareholder confidence amidst a promising financial trajectory marked by first-quarter sales surging by 37.5% year-over-year to CHF 111.2 million. Take a closer look at Comet Holding's potential here in our health report. Assess Comet Holding's past performance with our detailed historical performance reports. Dive into all 226 of the European High Growth Tech and AI Stocks we have identified here. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTBR:ARGX ENXTPA:BLV and SWX:COTN. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Business Upturn
2 hours ago
- Business Upturn
Glenmark Pharmaceuticals to launch Zanubrutinib (BRUKINSA) in India after DCGI approval
Glenmark Pharmaceuticals has announced the launch of zanubrutinib in India following approval by the Drugs Controller General of India (DCGI). The drug will be marketed under the brand name BRUKINSA®, developed by BeiGene (now BeOne Medicines), a global oncology company. This marks the introduction of the first Bruton's tyrosine kinase (BTK) inhibitor in India approved for the treatment of five B-cell malignancies: chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), Waldenström macroglobulinemia (WM), mantle cell lymphoma (MCL), marginal zone lymphoma (MZL), and follicular lymphoma (FL). BRUKINSA is approved in over 70 countries, backed by data from clinical studies such as ALPINE, ASPEN, and SEQUOIA. These trials have demonstrated consistent clinical outcomes across various B-cell cancers. The availability of BRUKINSA in India comes at a time when blood cancers continue to impact a large number of individuals. Estimates suggest that someone is diagnosed with blood cancer every five minutes in India, with annual deaths from the disease numbering around 70,000. The treatment has shown high response rates and the ability to maintain disease control in patients with different types of B-cell malignancies. It also offers dosing flexibility, allowing for once or twice-daily administration. In the ALPINE study, BRUKINSA was compared with ibrutinib in relapsed or refractory CLL and showed a lower rate of serious cardiac events and fewer treatment discontinuations due to cardiac-related issues. With its recent regulatory approval, BRUKINSA will now be available to patients in India who are affected by challenging hematological cancers. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
6 hours ago
- Business Upturn
PFMCrypto Announces Free and Sustainable Cloud Mining Technology for Bitcoin Users
Los Angeles, California, June 08, 2025 (GLOBE NEWSWIRE) — PFMCrypto, the cloud mining service operated by UK-registered and FCA-regulated Precision Financial Management Ltd (Company No. 11719896), has officially launched a sustainable mining platform that combines user-friendly cloud contracts with renewable energy. The company's service allows users to participate in Bitcoin mining without owning hardware, while its operations are powered by solar and wind energy—minimizing environmental impact and reducing operational costs. As technology continues to evolve, the global shift toward renewable energy is accelerating. PFMCrypto powers its cloud mining operations using renewable energy sources such as solar and wind power. This significantly reduces mining costs while returning excess electricity to the grid. This approach not only conserves energy but also delivers sustainable returns to investors—highlighting the enormous potential of green-powered mining. In the fast-paced world of cryptocurrencies, simplicity and profitability are key. For beginners seeking a reliable source of income, PFMCrypto's cloud mining service is an especially appealing option. What Is PFMCrypto Cloud Mining? PFMCrypto cloud mining is a remote cryptocurrency mining solution that supports a range of digital assets, including Bitcoin. Users leverage the mining company's computational power to earn profits without investing in hardware or handling technical maintenance. Through access to high-powered mining farms, PFMCrypto enables users to benefit from ongoing crypto mining rewards as complex blockchain problems are solved in real time. Key Benefits of PFMCrypto Cloud Mining Easy Investment: Users can invest effortlessly without complicated procedures. No Hardware Required: There's no need to buy expensive mining equipment, lowering the barrier to entry. No Technical Expertise Needed: Ideal for beginners, with minimal technical requirements. Zero Operational Costs: No electricity, maintenance, or other overhead expenses for the user. Flexible and Reliable: Users can adjust their investment strategy according to their individual goals. Instant Start: interested users can quickly start mining without cumbersome preparations. Why Choose PFMCrypto? PFMCrypto is committed to clean and efficient energy solutions. Founded in 2018 in the UK, the platform has grown to serve more than 9.2 million users globally. Since its inception, the company has focused exclusively on Bitcoin mining. Today, PFMCrypto operates more than 20 large-scale mining farms and reportedly accounts for approximately 6.2% of the global mining hash rate. Platform Advantages Cutting-Edge Equipment: PFMCrypto uses top-tier mining hardware from manufacturers like Bitmain, Antminer, and other energy-efficient rigs to ensure stable and high-yield mining performance. Legal and Globally Trusted: Operated by FCA-regulated Precision Financial Management (PFM) Ltd , PFMCrypto complies with all UK financial regulations and serves a global user base of over 9.2 million real users. User-Friendly Interface: Designed with intuitive navigation so even beginners can easily manage their accounts. Multi-Crypto Support: Supports settlement in various popular cryptocurrencies including USDT-TRC20, BTC, ETH, LTC, USDC, BNB, USDT-ERC20, BCH, DOGE, SOL (Solana), XRP, and more. Stable Daily Returns: Mining contracts yield daily returns, with principal automatically refunded upon contract expiration to protect investment security. Expert Team: PFMCrypto boasts a professional IT team and 24/7 live customer support to assist users at all times. Affiliate Program: Invite friends and earn referral bonuses of up to $18,999. How to Join PFMCrypto Sign up today and receive a $10 welcome bonus (plus $0.60 daily check-in rewards). a Contract: After registering, select a mining contract that suits your goals and budget. PFMCrypto offers a range of plans to fit both new and seasoned miners. Earning: Once your mining contract is activated, the platform's advanced technology handles the rest—ensuring your operation runs efficiently and maximizes your potential profits. Sample Investment Plans Trial Contract: Investment: $100 | Net Profit: $106.6 Classic Contract: Investment: $500 | Net Profit: $530.75 Classic Contract: Investment: $3,000 | Net Profit: $3,888 Prepaid Contract: Investment: $5,000 | Net Profit: $7,370 Advanced Contract: Investment: $10,000 | Net Profit: $17,240 As your mining activity progresses, your account will begin to accumulate earnings. You can track performance through your dashboard and withdraw profits whenever you're ready. In Summary PFMCrypto is a legally registered UK company authorized and regulated by the UK Financial Conduct Authority (FCA), adhering strictly to local regulations. The platform offers a seamless, low-barrier entry into crypto mining for both beginners and experienced investors, aiming to help users maximize their earnings with minimal effort. Start your hassle-free cloud mining journey with PFMCrypto and boost your income today! New users can get a $10 bonus. For more information, visit the official PFMCrypto website: Or download the mobile app from Google Play and the Apple App Store . Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
